Loading organizations...
§ Private Profile · Houston, TX, USA
Biopharmaceutical company developing novel oncology products for cancer.
ImmunoMet Therapeutics has raised $27.2M across 4 funding rounds.
ImmunoMet Therapeutics has raised $27.2M in total across 4 funding rounds.
ImmunoMet Therapeutics has raised $27.2M across 4 funding rounds. Most recently, it raised $7.0M Other Equity in February 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 8, 2021 | $7M Venture Round | — | — | Announced |
| Sep 1, 2018 | $10M Series B | — | — | Announced |
| Mar 7, 2017 | $5M Series B | — | Sungwuk KIM, G.n. Tech Venture Capital, Intervest, Mirae Asset Venture Investment, NHN Ventures, SL Investment | Announced |
| Mar 8, 2016 | $5.2M Series A | JAE Joon KIM | AJU Tech, G.n. Tech Venture Capital, Metavest Capital | Announced |
ImmunoMet Therapeutics has raised $27.2M in total across 4 funding rounds.
ImmunoMet Therapeutics's investors include Sungwuk Kim, G.N. Tech Venture Capital, InterVest, Mirae Asset Venture Investment, NHN Ventures, SL Investment, Jae Joon Kim, Aju Tech, Metavest Capital.